EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly …

A Stabile, A Pellegrino, E Mazzone… - European Urology …, 2022 - Elsevier
Context The role of positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …

Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022 - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up

JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part II of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of …

Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate-and high-risk prostate cancer: early oncological outcomes from a …

JFP Lestingi, GB Guglielmetti, QD Trinh, RF Coelho… - European urology, 2021 - Elsevier
Background The role of extended pelvic lymph node dissection (EPLND) in the surgical
management of prostate cancer (PCa) patients remains controversial, mainly because of a …

A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic …

G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori… - European urology, 2019 - Elsevier
Background Available models for predicting lymph node invasion (LNI) in prostate cancer
(PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men …

[HTML][HTML] Prostate-specific membrane antigen radioguided surgery to detect nodal metastases in primary prostate cancer patients undergoing robot-assisted radical …

G Gandaglia, E Mazzone, A Stabile, A Pellegrino… - European urology, 2022 - Elsevier
Background Extended pelvic nodal dissection (ePLND) represents the gold standard for
nodal staging in prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) …

Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive …

GE Cacciamani, M Maas, N Nassiri, D Ortega… - European urology …, 2021 - Elsevier
Context Pelvic lymph node dissection (PLND) yields the most accurate staging in patients
undergoing radical prostatectomy (RP) for prostate cancer (PCa), although it can be …

[HTML][HTML] Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

BHE Jansen, YJL Bodar, GJC Zwezerijnen… - European journal of …, 2021 - Springer
Purpose The detection of lymph-node metastases (N1) with conventional imaging such as
magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for …

Prospective validation of gallium-68 prostate specific membrane antigen-positron emission tomography/computerized tomography for primary staging of prostate …

LWM van Kalmthout, HHE van Melick… - The Journal of …, 2020 - auajournals.org
Purpose: Prospective validation of 68Ga prostate specific membrane antigen positron
emission tomography/computerized tomography is lacking in initial staging of prostate …